Evidence map›Paper›PMID 18669884›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2008

Site-specific effects of PECAM-1 on atherosclerosis in LDL receptor-deficient mice.

Reema Goel, Benjamin R Schrank, Shikha Arora, Brian Boylan, Barbara Fleming, Hiroto Miura, Peter J Newman, Robert C Molthen, Debra K Newman

Open access · greenAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 1 synthesis or guideline pooled it, 104 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Mechanosensory entities and functionality of endothelial cells.Frontiers in cell and developmental biology · 2024
    Review
  6. Review
  7. Response of cells and tissues to shear stress.Journal of cell science · 2023
    Review
  8. Article
  9. Vascular mechanotransduction.Physiological reviews · 2023
    Review
  10. Article
  11. Article
  12. Journal of clinical medicine · 2022
    Article
  13. Article
  14. Review
  15. Review
  16. Where the Action Is-Leukocyte Recruitment in Atherosclerosis.Frontiers in cardiovascular medicine · 2021
    Review
  17. Article
  18. Article
  19. High-fat diet-induced GAIT element-mediated translational silencing of mRNAs encoding inflammatory proteins in macrophage protects against atherosclerosis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  20. Generation of PECAM-1 (CD31) conditional knockout mice.Genesis (New York, N.Y. : 2000) · 2020
    Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Reema GoelBlood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI 53201, USA.
Benjamin R Schrank
Shikha Arora
Brian Boylan
Barbara Fleming
Hiroto Miura
Peter J Newman
Robert C Molthen
Debra K Newman
Versiti Blood Center of Wisconsin · USMilwaukee VA Medical Center · US

Funding

MOLECULAR BIOLOGY &FUNCTION OF PLATELET MEMBRANE GP130R01HL040926 · NHLBI · VERSITI WISCONSIN, INC. · PI NEWMAN, PETER J · 1988 to 2017
$7.4M
Vascular Signaling by Free RadicalsP01HL068769 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HARDER, DAVID RAE · 2002 to 2006
$7.2M
Role of IKCa Channels in Vascular RemodelingR01HL080173 · NHLBI · UNIVERSITY OF NEVADA RENO · PI MIURA, HIROTO · 2007 to 2011
$1.9M
Negative regulation of platelet activityR01HL090883 · NHLBI · VERSITI WISCONSIN, INC. · PI NEWMAN, DEBRA KAY · 2008 to 2010
$1.1M
NHLBI NIH HHS HL-40926NHLBI NIH HHS HL-68769NHLBI NIH HHS P01 HL068769NHLBI NIH HHS R01 HL040926NHLBI NIH HHS R01 HL080173NHLBI NIH HHS R01 HL090883
6 · The paper itself

Abstract

objectiveAtherosclerosis is a vascular disease that involves lesion formation at sites of disturbed flow under the influence of genetic and environmental factors. Endothelial expression of adhesion molecules that enable infiltration of immune cells is important for lesion development. Platelet/endothelial cell adhesion molecule-1 (PECAM-1; CD31) is an adhesion and signaling receptor expressed by many cells involved in atherosclerotic lesion development. PECAM-1 transduces signals required for proinflammatory adhesion molecule expression at atherosusceptible sites; thus, it is predicted to be proatherosclerotic. PECAM-1 also inhibits inflammatory responses, on which basis it is predicted to be atheroprotective. METHODS AND

resultsWe evaluated herein the effect of PECAM-1 deficiency on development of atherosclerosis in LDL receptor-deficient mice. We found that PECAM-1 has both proatherosclerotic and atheroprotective effects, but that the former dominate in the inner curvature of the aortic arch whereas the latter dominate in the aortic sinus, branching arteries, and descending aorta. Endothelial cell expression of PECAM-1 was sufficient for its atheroprotective effects in the aortic sinus but not in the descending aorta, where the atheroprotective effects of PECAM-1 also required its expression on bone marrow-derived cells.

conclusionsWe conclude that PECAM-1 influences initiation and progression of atherosclerosis both positively and negatively, and that it does so in a site-specific manner.

Indexed as

AnimalsAorta, ThoracicAtherosclerosisBone Marrow CellsDietary FatsDisease Models, AnimalDisease ProgressionEndothelial CellsFemaleMaleMiceMice, Inbred C57BLMice, KnockoutPlatelet Endothelial Cell Adhesion Molecule-1Receptors, LDLSinus of ValsalvaDietary FatsPlatelet Endothelial Cell Adhesion Molecule-1Receptors, LDL

Identifiers

PMID18669884
PMCPMC3013511
OpenAlexW2148245148

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.